247 related articles for article (PubMed ID: 14980551)
1. Cluster analysis in kinetic modelling of the brain: a noninvasive alternative to arterial sampling.
Liptrot M; Adams KH; Martiny L; Pinborg LH; Lonsdale MN; Olsen NV; Holm S; Svarer C; Knudsen GM
Neuroimage; 2004 Feb; 21(2):483-93. PubMed ID: 14980551
[TBL] [Abstract][Full Text] [Related]
2. Test-retest variability of serotonin 5-HT2A receptor binding measured with positron emission tomography and [18F]altanserin in the human brain.
Smith GS; Price JC; Lopresti BJ; Huang Y; Simpson N; Holt D; Mason NS; Meltzer CC; Sweet RA; Nichols T; Sashin D; Mathis CA
Synapse; 1998 Dec; 30(4):380-92. PubMed ID: 9826230
[TBL] [Abstract][Full Text] [Related]
3. Analyses of [(18)F]altanserin bolus injection PET data. II: consideration of radiolabeled metabolites in humans.
Price JC; Lopresti BJ; Meltzer CC; Smith GS; Mason NS; Huang Y; Holt DP; Gunn RN; Mathis CA
Synapse; 2001 Jul; 41(1):11-21. PubMed ID: 11354009
[TBL] [Abstract][Full Text] [Related]
4. Optimized Quantification of Translocator Protein Radioligand ¹⁸F-DPA-714 Uptake in the Brain of Genotyped Healthy Volunteers.
Lavisse S; García-Lorenzo D; Peyronneau MA; Bodini B; Thiriez C; Kuhnast B; Comtat C; Remy P; Stankoff B; Bottlaender M
J Nucl Med; 2015 Jul; 56(7):1048-54. PubMed ID: 26025960
[TBL] [Abstract][Full Text] [Related]
5. Tracer Kinetic Analysis of (S)-¹⁸F-THK5117 as a PET Tracer for Assessing Tau Pathology.
Jonasson M; Wall A; Chiotis K; Saint-Aubert L; Wilking H; Sprycha M; Borg B; Thibblin A; Eriksson J; Sörensen J; Antoni G; Nordberg A; Lubberink M
J Nucl Med; 2016 Apr; 57(4):574-81. PubMed ID: 26795290
[TBL] [Abstract][Full Text] [Related]
6. [¹⁸F]Altanserin and small animal PET: impact of multidrug efflux transporters on ligand brain uptake and subsequent quantification of 5-HT₂A receptor densities in the rat brain.
Kroll T; Elmenhorst D; Matusch A; Celik AA; Wedekind F; Weisshaupt A; Beer S; Bauer A
Nucl Med Biol; 2014 Jan; 41(1):1-9. PubMed ID: 24120220
[TBL] [Abstract][Full Text] [Related]
7. Analyses of [(18)F] altanserin bolus injection PET data. I: consideration of radiolabeled metabolites in baboons.
Price JC; Lopresti BJ; Mason NS; Holt DP; Huang Y; Mathis CA
Synapse; 2001 Jul; 41(1):1-10. PubMed ID: 11354008
[TBL] [Abstract][Full Text] [Related]
8. Assessment of serotonin release capacity in the human brain using dexfenfluramine challenge and [18F]altanserin positron emission tomography.
Quednow BB; Treyer V; Hasler F; Dörig N; Wyss MT; Burger C; Rentsch KM; Westera G; Schubiger PA; Buck A; Vollenweider FX
Neuroimage; 2012 Feb; 59(4):3922-32. PubMed ID: 21996132
[TBL] [Abstract][Full Text] [Related]
9. Quantification of the glycine transporter 1 in rhesus monkey brain using [18F]MK-6577 and a model-based input function.
Sanabria-Bohórquez SM; Joshi AD; Holahan M; Daneker L; Riffel K; Williams M; Li W; Cook JJ; Hamill TG
Neuroimage; 2012 Feb; 59(3):2589-99. PubMed ID: 21930214
[TBL] [Abstract][Full Text] [Related]
10. Quantification of [18F]diprenorphine kinetics in the human brain with compartmental and non-compartmental modeling approaches.
Spilker ME; Sprenger T; Valet M; Henriksen G; Wagner K; Wester HJ; Toelle TR; Boecker H
Neuroimage; 2004 Aug; 22(4):1523-33. PubMed ID: 15275909
[TBL] [Abstract][Full Text] [Related]
11. A database of [(18)F]-altanserin binding to 5-HT(2A) receptors in normal volunteers: normative data and relationship to physiological and demographic variables.
Adams KH; Pinborg LH; Svarer C; Hasselbalch SG; Holm S; Haugbøl S; Madsen K; Frøkjaer V; Martiny L; Paulson OB; Knudsen GM
Neuroimage; 2004 Mar; 21(3):1105-13. PubMed ID: 15006678
[TBL] [Abstract][Full Text] [Related]
12. Validation of a tracer kinetic model for the quantification of 5-HT(2A) receptors in human brain with [(11)C]MDL 100,907.
Hinz R; Bhagwagar Z; Cowen PJ; Cunningham VJ; Grasby PM
J Cereb Blood Flow Metab; 2007 Jan; 27(1):161-72. PubMed ID: 16685260
[TBL] [Abstract][Full Text] [Related]
13. Simplified quantification of nicotinic receptors with 2[18F]F-A-85380 PET.
Mitkovski S; Villemagne VL; Novakovic KE; O'Keefe G; Tochon-Danguy H; Mulligan RS; Dickinson KL; Saunder T; Gregoire MC; Bottlaender M; Dolle F; Rowe CC
Nucl Med Biol; 2005 Aug; 32(6):585-91. PubMed ID: 16026705
[TBL] [Abstract][Full Text] [Related]
14. Serotonin 5HT2 receptor imaging in the human brain using positron emission tomography and a new radioligand, [18F]altanserin: results in young normal controls.
Sadzot B; Lemaire C; Maquet P; Salmon E; Plenevaux A; Degueldre C; Hermanne JP; Guillaume M; Cantineau R; Comar D
J Cereb Blood Flow Metab; 1995 Sep; 15(5):787-97. PubMed ID: 7673371
[TBL] [Abstract][Full Text] [Related]
15. Direct comparison of [(18) F]MH.MZ and [(18) F] altanserin for 5-HT2A receptor imaging with PET.
Hansen HD; Ettrup A; Herth MM; Dyssegaard A; Ratner C; Gillings N; Knudsen GM
Synapse; 2013 Jun; 67(6):328-37. PubMed ID: 23390031
[TBL] [Abstract][Full Text] [Related]
16. Suitability of [18F]altanserin and PET to determine 5-HT2A receptor availability in the rat brain: in vivo and in vitro validation of invasive and non-invasive kinetic models.
Kroll T; Elmenhorst D; Matusch A; Wedekind F; Weisshaupt A; Beer S; Bauer A
Mol Imaging Biol; 2013 Aug; 15(4):456-67. PubMed ID: 23456885
[TBL] [Abstract][Full Text] [Related]
17. Quantitative analysis of dopamine transporters in human brain using [11C]PE2I and positron emission tomography: evaluation of reference tissue models.
Seki C; Ito H; Ichimiya T; Arakawa R; Ikoma Y; Shidahara M; Maeda J; Takano A; Takahashi H; Kimura Y; Suzuki K; Kanno I; Suhara T
Ann Nucl Med; 2010 May; 24(4):249-60. PubMed ID: 20364374
[TBL] [Abstract][Full Text] [Related]
18. Visualisation of loss of 5-HT2A receptors with age in healthy volunteers using [18F]altanserin and positron emission tomographic imaging.
Rosier A; Dupont P; Peuskens J; Bormans G; Vandenberghe R; Maes M; de Groot T; Schiepers C; Verbruggen A; Mortelmans L
Psychiatry Res; 1996 Nov; 68(1):11-22. PubMed ID: 9027929
[TBL] [Abstract][Full Text] [Related]
19. Kinetic analysis of [(11)C]MP4A using a high-radioactivity brain region that represents an integrated input function for measurement of cerebral acetylcholinesterase activity without arterial blood sampling.
Nagatsuka Si S; Fukushi K; Shinotoh H; Namba H; Iyo M; Tanaka N; Aotsuka A; Ota T; Tanada S; Irie T
J Cereb Blood Flow Metab; 2001 Nov; 21(11):1354-66. PubMed ID: 11702050
[TBL] [Abstract][Full Text] [Related]
20. Noninvasive quantitation of cerebral blood flow using oxygen-15-water and a dual-PET system.
Iida H; Miura S; Shoji Y; Ogawa T; Kado H; Narita Y; Hatazawa J; Eberl S; Kanno I; Uemura K
J Nucl Med; 1998 Oct; 39(10):1789-98. PubMed ID: 9776289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]